Emerging role of mucins in epithelial to mesenchymal transition

Current Cancer Drug Targets

Volumn 13, Issue 9, 2013, Pages 945-956

  Ponnusamy, Moorthy P ^a   Seshacharyulu, Parthasarathy ^a   Lakshmanan, Imayavaramban ^a   Vaz, Arokia P ^a   Chugh, Seema ^a   Batra, Surinder K ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cancer stem cells; EMT signaling; EMT transcription factors; MUC1; MUC16; MUC4; Mucins; Tumor microenvironment

Indexed keywords

ANDROGEN RECEPTOR; BETA CATENIN; CYTOKERATIN 18; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FOCAL ADHESION KINASE; FRIZZLED PROTEIN; MICRORNA 200; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MUCIN; MUCIN 1; MUCIN 4; MUCIN 5AC; NERVE CELL ADHESION MOLECULE; NOTCH RECEPTOR; OCCLUDIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SECRETED FRIZZLED RELATED PROTEIN 1; SMAD3 PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB1; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG; UVOMORULIN; VIMENTIN; WNT PROTEIN;

CANCER STEM CELL; CELL INVASION; CELL PROLIFERATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; METASTASIS; NONHUMAN; OVARY CANCER; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MUCINS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84890825478     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/15680096113136660100     Document Type: Review

References (95)

1. Hollingsworth, M. A.; Swanson, B. J. Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer 2004, 4, 45-60.
2. Chaturvedi, P.; Singh, A. P.; Batra, S. K. Structure, evolution, and biology of the MUC4 mucin. FASEB J. 2008, 22, 966-981.
3. Ponnusamy, M. P.; Seshacharyulu, P.; Vaz, A.; Dey, P.; Batra, S. K. MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells. J. Ovarian Res. 2011, 4, 7.
4. Bafna, S.; Kaur, S.; Momi, N.; Batra, S. K. Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin. Br. J. Cancer 2009, 101, 1155-1161.
5. Mimeault, M.; Johansson, S. L.; Senapati, S.; Momi, N.; Chakraborty, S.; Batra, S. K. MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies. Cancer Lett. 2010, 295, 69-84.
6. Engelmann, K.; Shen, H.; Finn, O. J. MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1. Cancer Res. 2008, 68, 2419-2426.
7. Jing, Y.; Han, Z.; Liu, Y.; Sun, K.; Zhang, S.; Jiang, G.; Li, R.; Gao, L.; Zhao, X.; Wu, D.; Cai, X.; Wu, M.; Wei, L. Mesenchymal stem cells in inflammation microenvironment accelerates hepatocellular carcinoma metastasis by inducing epithelialmesenchymal transition. PLoS One 2012, 7, e43272.
8. Kalluri, R.; Zeisberg, M. Fibroblasts in cancer. Nat. Rev. Cancer 2006, 6, 392-401.
9. Kikuta, K.; Masamune, A.; Watanabe, T.; Ariga, H.; Itoh, H.; Hamada, S.; Satoh, K.; Egawa, S.; Unno, M.; Shimosegawa, T. Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells. Biochem. Biophys. Res. Commun. 2010, 403, 380-384.
10. Orimo, A.; Gupta, P. B.; Sgroi, D. C.; Arenzana-Seisdedos, F.; Delaunay, T.; Naeem, R.; Carey, V. J.; Richardson, A. L.; Weinberg, R. A. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121, 335-348.
11. Batlle, E.; Sancho, E.; Franci, C.; Dominguez, D.; Monfar, M.; Baulida, J.; Garcia De, H. A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2000, 2, 84-89.
12. Cano, A.; Perez-Moreno, M. A.; Rodrigo, I.; Locascio, A.; Blanco, M. J.; del Barrio, M. G.; Portillo, F.; Nieto, M. A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2000, 2, 76-83.
13. Hajra, K. M.; Chen, D. Y.; Fearon, E. R. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 2002, 62, 1613-1618.
14. Comijn, J.; Berx, G.; Vermassen, P.; Verschueren, K.; van, G. L.; Bruyneel, E.; Mareel, M.; Huylebroeck, D.; van, R. F. The twohanded E box binding zinc finger protein SIP1 downregulates Ecadherin and induces invasion. Mol. Cell 2001, 7, 1267-1278.
15. Eger, A.; Aigner, K.; Sonderegger, S.; Dampier, B.; Oehler, S.; Schreiber, M.; Berx, G.; Cano, A.; Beug, H.; Foisner, R. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene. 2005, 24(14), 2375-2385.
16. Wang, X.; Zheng, M.; Liu, G.; Xia, W.; McKeown-Longo, P. J.; Hung, M. C.; Zhao, J. Kruppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion. Cancer Res. 2007, 67, 7184-7193.
17. Perez-Moreno, M. A.; Locascio, A.; Rodrigo, I.; Dhondt, G.; Portillo, F.; Nieto, M. A.; Cano, A. A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J. Biol. Chem. 2001, 276, 27424-27431.
18. Fernando, R. I.; Litzinger, M.; Trono, P.; Hamilton, D. H.; Schlom, J.; Palena, C. The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells. J. Clin. Invest. 2010, 120, 533-544.
19. De, C. B.; Gilbert, B.; Stove, C.; Bruyneel, E.; van, R. F.; Berx, G. The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. Cancer Res. 2005, 65, 6237-6244.
20. Moreno-Bueno, G.; Cubillo, E.; Sarrio, D.; Peinado, H.; Rodriguez-Pinilla, S. M.; Villa, S.; Bolos, V.; Jorda, M.; Fabra, A.; Portillo, F.; Palacios, J.; Cano, A. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res. 2006, 66, 9543-9556.
21. Vandewalle, C.; Comijn, J.; De, C. B.; Vermassen, P.; Bruyneel, E.; Andersen, H.; Tulchinsky, E.; van, R. F.; Berx, G. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res. 2005, 33, 6566-6578.
22. Yang, J.; Mani, S. A.; Donaher, J. L.; Ramaswamy, S.; Itzykson, R. A.; Come, C.; Savagner, P.; Gitelman, I.; Richardson, A.; Weinberg, R.A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117, 927-939.
23. McCoy, E. L.; Iwanaga, R.; Jedlicka, P.; Abbey, N. S.; Chodosh, L. A.; Heichman, K. A.; Welm, A. L.; Ford, H. L. Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition. J. Clin. Invest 2009, 119, 2663-2677.
24. Mani, S. A.; Yang, J.; Brooks, M.; Schwaninger, G.; Zhou, A.; Miura, N.; Kutok, J. L.; Hartwell, K.; Richardson, A. L.; Weinberg, R. A. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc. Natl. Acad. Sci. USA 2007, 104, 10069-10074.
25. Sobrado, V. R.; Moreno-Bueno, G.; Cubillo, E.; Holt, L. J.; Nieto, M. A.; Portillo, F.; Cano, A. The class I bHLH factors E2-2A and E2-2B regulate EMT. J. Cell Sci. 2009, 122, 1014-1024.
26. Ocana, O. H.; Corcoles, R.; Fabra, A.; Moreno-Bueno, G.; Acloque, H.; Vega, S.; Barrallo-Gimeno, A.; Cano, A.; Nieto, M.A. Metastatic colonization requires the repression of the epithelialmesenchymal transition inducer Prrx1. Cancer Cell 2012, 22, 709-724.
27. Frisch, S. M. The epithelial cell default-phenotype hypothesis and its implications for cancer. Bioessays 1997, 19, 705-709.
28. Korpal, M.; Lee, E. S.; Hu, G.; Kang, Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 2008, 283, 14910-14914.
29. Ahn, S. M.; Cha, J. Y.; Kim, J.; Kim, D.; Trang, H. T.; Kim, Y. M.; Cho, Y. H.; Park, D.; Hong, S. Smad3 regulates E-cadherin via miRNA-200 pathway. Oncogene 2012, 31, 3051-3059.
30. Zhang, Z.; Liu, S.; Shi, R.; Zhao, G. miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-tomesenchymal transition. Cancer Genet. 2011, 204, 486-491.
31. Blobe, G. C.; Schiemann, W. P.; Lodish, H. F. Role of transforming growth factor beta in human disease. N. Engl. J. Med. 2000, 342, 1350-1358.
32. Koinuma, D.; Tsutsumi, S.; Kamimura, N.; Imamura, T.; Aburatani, H.; Miyazono, K. Promoter-wide analysis of Smad4 binding sites in human epithelial cells. Cancer Sci. 2009, 100, 2133-2142.
33. Tian, M.; Neil, J. R.; Schiemann, W. P. Transforming growth factor-beta and the hallmarks of cancer. Cell Signal. 2011, 23, 951-962.
34. Leptin, M. TWIST and SNAIL as positive and negative regulators during Drosophila mesoderm development. Genes Dev. 1991, 5, 1568-1576.
35. Wendt, M. K.; Tian, M.; Schiemann, W. P. Deconstructing the mechanisms and consequences of TGF-beta-induced EMT during cancer progression. Cell Tissue Res. 2012, 347, 85-101.
36. D'Inzeo, S.; Nicolussi, A.; Donini, C. F.; Zani, M.; Mancini, P.; Nardi, F.; Coppa, A. A novel human Smad4 mutation is involved in papillary thyroid carcinoma progression. Endocr. Relat. Cancer 2012, 19, 39-55.
37. Araki, K.; Shimura, T.; Suzuki, H.; Tsutsumi, S.; Wada, W.; Yajima, T.; Kobayahi, T.; Kubo, N.; Kuwano, H. E/N-cadherin switch mediates cancer progression via TGF-beta-induced epithelialto-mesenchymal transition in extrahepatic cholangiocarcinoma. Br. J. Cancer 2011, 105, 1885-1893.
38. Yook, J. I.; Li, X. Y.; Ota, I.; Hu, C.; Kim, H. S.; Kim, N. H.; Cha, S. Y.; Ryu, J. K.; Choi, Y. J.; Kim, J.; Fearon, E. R.; Weiss, S. J. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat. Cell Biol. 2006, 8, 1398-1406.
39. Gauger, K. J.; Chenausky, K. L.; Murray, M. E.; Schneider, S. S. SFRP1 reduction results in an increased sensitivity to TGF-beta signaling. BMC Cancer 2011, 11, 59-11.
40. Kwon, C. Y.; Kim, K. R.; Choi, H. N.; Chung, M. J.; Noh, S. J.; Kim, D. G.; Kang, M. J.; Lee, D. G.; Moon, W. S. The role of serum response factor in hepatocellular carcinoma: implications for disease progression. Int. J. Oncol. 2010, 37, 837-844.
41. Doble, B. W.; Woodgett, J. R. Role of glycogen synthase kinase-3 in cell fate and epithelial-mesenchymal transitions. Cells Tissues Organs 2007, 185, 73-84.
42. Heuberger, J.; Birchmeier, W. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb. Perspect. Biol. 2010, 2, a002915.
43. Bolos, V.; Grego-Bessa, J.; de la Pompa, J. L. Notch signaling in development and cancer. Endocr. Rev. 2007, 28, 339-363.
44. Sharma, A.; Paranjape, A. N.; Rangarajan, A.; Dighe, R. R. A monoclonal antibody against human Notch1 ligand-binding domain depletes subpopulation of putative breast cancer stem-like cells. Mol. Cancer Ther. 2012, 11, 77-86.
45. Wang, Z.; Li, Y.; Ahmad, A.; Azmi, A. S.; Banerjee, S.; Kong, D.; Sarkar, F. H. Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. Biochim. Biophys. Acta 2010, 1806, 258-267.
46. Timmerman, L. A.; Grego-Bessa, J.; Raya, A.; Bertran, E.; Perez-Pomares, J. M.; Diez, J.; Aranda, S.; Palomo, S.; McCormick, F.; Izpisua-Belmonte, J. C.; de la Pompa, J. L. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 2004, 18, 99-115.
47. Bao, B.; Wang, Z.; Ali, S.; Kong, D.; Li, Y.; Ahmad, A.; Banerjee, S.; Azmi, A. S.; Miele, L.; Sarkar, F. H. Notch-1 induces epithelialmesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett. 2011, 307, 26-36.
48. Brabletz, S.; Bajdak, K.; Meidhof, S.; Burk, U.; Niedermann, G.; Firat, E.; Wellner, U.; Dimmler, A.; Faller, G.; Schubert, J.; Brabletz, T. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J. 2011, 30, 770-782.
49. Yang, Y.; Ahn, Y. H.; Gibbons, D. L.; Zang, Y.; Lin, W.; Thilaganathan, N.; Alvarez, C. A.; Moreira, D. C.; Creighton, C. J.; Gregory, P. A.; Goodall, G. J.; Kurie, J. M. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. J. Clin. Invest. 2011, 121, 1373-1385.
50. Louro, I. D.; Bailey, E. C.; Li, X.; South, L. S.; McKie-Bell, P. R.; Yoder, B. K.; Huang, C. C.; Johnson, M. R.; Hill, A. E.; Johnson, R. L.; Ruppert, J. M. Comparative gene expression profile analysis of GLI and c-MYC in an epithelial model of malignant transformation. Cancer Res. 2002, 62, 5867-5873.
51. Maitah, M. Y.; Ali, S.; Ahmad, A.; Gadgeel, S.; Sarkar, F. H. Upregulation of sonic hedgehog contributes to TGF-beta1-induced epithelial to mesenchymal transition in NSCLC cells. PLoS One 2011, 6, e16068.
52. Yoo, Y. A.; Kang, M. H.; Lee, H. J.; Kim, B. H.; Park, J. K.; Kim, H. K.; Kim, J. S.; Oh, S. C. Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer Res. 2011, 71, 7061-7070.
53. Joost, S.; Almada, L. L.; Rohnalter, V.; Holz, P. S.; Vrabel, A. M.; Fernandez-Barrena, M. G.; McWilliams, R. R.; Krause, M.; Fernandez-Zapico, M. E.; Lauth, M. GLI1 inhibition promotes epithelial-to-mesenchymal transition in pancreatic cancer cells. Cancer Res. 2012, 72, 88-99.
54. Bafna, S.; Singh, A. P.; Moniaux, N.; Eudy, J. D.; Meza, J. L.; Batra, S. K. MUC4, a multifunctional transmembrane glycoprotein, induces oncogenic transformation of NIH3T3 mouse fibroblast cells. Cancer Res. 2008, 68, 9231-9238.
55. Chaturvedi, P.; Singh, A. P.; Chakraborty, S.; Chauhan, S. C.; Bafna, S.; Meza, J. L.; Singh, P. K.; Hollingsworth, M. A.; Mehta, P. P.; Batra, S. K. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. Cancer Res. 2008, 68, 2065-2070.
56. Mukhopadhyay, P.; Lakshmanan, I.; Ponnusamy, M. P.; Chakraborty, S.; Jain, M.; Pai, P.; Smith, L. M.; Lele, S. M.; Batra, S. K. MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells. PLoS One 2013, 8, e54455.
57. Ponnusamy, M. P.; Singh, A. P.; Jain, M.; Chakraborty, S.; Moniaux, N.; Batra, S. K. MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells. Br. J. Cancer. 2008, 99, 520-526.
58. Ponnusamy, M. P.; Lakshmanan, I.; Jain, M.; Das, S.; Chakraborty, S.; Dey, P.; Batra, S.K. MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells. Oncogene 2010, 29, 5741-5754.
59. Rachagani, S.; Macha, M. A.; Ponnusamy, M. P.; Haridas, D.; Kaur, S.; Jain, M.; Batra, S. K. MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1. Carcinogenesis 2012, 33, 1953-1964.
60. Deng, J.; Wang, L.; Chen, H.; Li, L.; Ma, Y.; Ni, J.; Li, Y. The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression. Cancer Metastasis Rev. 2013. [Epub ahead of print]
61. Rajabi, H.; Jin, C.; Ahmad, R.; McClary, C.; Joshi, M. D.; Kufe, D. Mucin 1 oncoprotein expression is suppressed by the Mir-125b Oncomir. Genes Cancer. 2010, 1, 62-68.
62. Rajabi, H.; Alam, M.; Takahashi, H.; Kharbanda, A.; Guha, M.; Ahmad, R.; Kufe, D. MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition. Oncogene. 2013, 10. [Epub ahead of print]
63. Roy, L. D.; Sahraei, M.; Subramani, D. B.; Besmer, D.; Nath, S.; Tinder, T. L.; Bajaj, E.; Shanmugam, K.; Lee, Y. Y.; Hwang, S. I.; Gendler, S. J.; Mukherjee, P. MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition. Oncogene 2011, 30, 1449-1459.
64. Horn, G.; Gaziel, A.; Wreschner, D. H.; Smorodinsky, N. I.; Ehrlich, M. ERK and PI3K regulate different aspects of the epithelial to mesenchymal transition of mammary tumor cells induced by truncated MUC1. Exp. Cell Res. 2009, 315, 1490-1504.
65. Rajabi, H.; Ahmad, R.; Jin, C.; Joshi, M. D.; Guha, M.; Alam, M.; Kharbanda, S.; Kufe, D. MUC1-C oncoprotein confers androgenindependent growth of human prostate cancer cells. Prostate 2012, 72, 1659-1668.
66. Majhi, P. D.; Lakshmanan, I.; Ponnusamy, M. P.; Jain, M.; Das, S.; Kaur, S.; Shimizu, S. T.; West, W. W.; Johansson, S. L.; Smith, L. M.; Yu, F.; Rolle, C. E.; Sharma, P.; Carey, G. B.; Batra, S. K.; Ganti, A. K. Pathobiological implications of MUC4 in non-smallcell lung cancer. J. Thorac. Oncol. 2013, 8, 398-407.
67. Comamala, M.; Pinard, M.; Theriault, C.; Matte, I.; Albert, A.; Boivin, M.; Beaudin, J.; Piche, A.; Rancourt, C. Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells. Br. J. Cancer 2011, 104, 989-999.
68. Theriault, C.; Pinard, M.; Comamala, M.; Migneault, M.; Beaudin, J.; Matte, I.; Boivin, M.; Piche, A.; Rancourt, C. MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis. Gynecol. Oncol. 2011, 121, 434-443.
69. Bast, R. C. Jr.; Spriggs, D. R. More than a biomarker: CA125 may contribute to ovarian cancer pathogenesis. Gynecol. Oncol. 2011, 121, 429-430.
70. Gubbels, J. A.; Belisle, J.; Onda, M.; Rancourt, C.; Migneault, M.; Ho, M.; Bera, T. K.; Connor, J.; Sathyanarayana, B. K.; Lee, B.; Pastan, I.; Patankar, M. S. Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors. Mol. Cancer 2006, 5, 50.
71. Bara, J.; Chastre, E.; Mahiou, J.; Singh, R. L.; Forgue-Lafitte, M. E.; Hollande, E.; Godeau, F. Gastric M1 mucin, an early oncofetal marker of colon carcinogenesis, is encoded by the MUC5AC gene. Int. J. Cancer 1998, 75, 767-773.
72. Lesuffleur, T.; Kornowski, A.; Augeron, C.; Dussaulx, E.; Barbat, A.; Laboisse, C.; Zweibaum, A. Increased growth adaptability to 5-fluorouracil and methotrexate of HT-29 sub-populations selected for their commitment to differentiation. Int. J. Cancer 1991, 49, 731-737.
73. Sylvester, P. A.; Myerscough, N.; Warren, B. F.; Carlstedt, I.; Corfield, A. P.; Durdey, P.; Thomas, M. G. Differential expression of the chromosome 11 mucin genes in colorectal cancer. J. Pathol. 2001, 195, 327-335.
74. Inaguma, S.; Kasai, K.; Ikeda, H. GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin. Oncogene 2011, 30, 714-723.
75. Yamazoe, S.; Tanaka, H.; Sawada, T.; Amano, R.; Yamada, N.; Ohira, M.; Hirakawa, K. RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells. J. Exp. Clin. Cancer Res. 2010, 23, 29:53.
76. Truant, S.; Bruyneel, E.; Gouyer, V.; De, W. O.; Pruvot, F. R.; Mareel, M.; Huet, G. Requirement of both mucins and proteoglycans in cell-cell dissociation and invasiveness of colon carcinoma HT-29 cells. Int. J. Cancer 2003, 104, 683-694.
77. Valque, H.; Gouyer, V.; Gottrand, F.; Desseyn, J. L. MUC5B leads to aggressive behavior of breast cancer MCF7 cells. PLoS One 2012, 7, e46699.
78. Leir, S. H.; Harris, A. MUC6 mucin expression inhibits tumor cell invasion. Exp. Cell Res. 2011, 317, 2408-2419.
79. Singh, A.; Settleman, J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010, 29, 4741-4751.
80. Mani, S. A.; Guo, W.; Liao, M. J.; Eaton, E. N.; Ayyanan, A.; Zhou, A. Y.; Brooks, M.; Reinhard, F.; Zhang, C. C.; Shipitsin, M.; Campbell, L. L.; Polyak, K.; Brisken, C.; Yang, J.; Weinberg, R. A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133, 704-715.
81. Wellner, U.; Schubert, J.; Burk, U. C.; Schmalhofer, O.; Zhu, F.; Sonntag, A.; Waldvogel, B.; Vannier, C.; Darling, D.; zur, H. A.; Brunton, V. G.; Morton, J.; Sansom, O.; Schuler, J.; Stemmler, M. P.; Herzberger, C.; Hopt, U.; Keck, T.; Brabletz, S.; Brabletz, T. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol. 2009, 11, 1487-1495.
82. Tirino, V.; Camerlingo, R.; Bifulco, K.; Irollo, E.; Montella, R.; Paino, F.; Sessa, G.; Carriero, M. V.; Normanno, N.; Rocco, G.; Pirozzi, G. TGF-beta1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133(+) A549 cell fraction. Cell Death Dis. 2013, 4, e620.
83. Gassenmaier, M.; Chen, D.; Buchner, A.; Henkel, L.; Schiemann, M.; Mack, B.; Schendel, D. J.; Zimmermann, W.; Pohla, H. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis. Stem Cells 2013, 31(8), 1467-1476.
84. Hiraga, T.; Nakajima, T.; Ozawa, H. Bone resorption induced by a metastatic human melanoma cell line. Bone 1995, 16, 349-356.
85. Hiraga, T.; Nakamura, H. Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals. Int. J. Cancer 2009, 124, 215-222.
86. Iguchi, H.; Tanaka, S.; Ozawa, Y.; Kashiwakuma, T.; Kimura, T.; Hiraga, T.; Ozawa, H.; Kono, A. An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis. Cancer Res. 1996, 56, 4040-4043.
87. Giudice, F. S.; Pinto, D. S. Jr.; Nor, J. E.; Squarize, C. H.; Castilho, R. M. Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer. PLoS One 2013, 8, e58672.
88. Giannoni, E.; Bianchini, F.; Calorini, L.; Chiarugi, P. Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness. Antioxid. Redox Signal. 2011, 14, 2361-2371.
89. Sullivan, N. J.; Sasser, A. K.; Axel, A. E.; Vesuna, F.; Raman, V.; Ramirez, N.; Oberyszyn, T. M.; Hall, B. M. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 2009, 28, 2940-2947.
90. Zavadil, J.; Bottinger, E. P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005, 24, 5764-5774.
91. Bates, R. C.; Mercurio, A. M. Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol. Biol. Cell. 2003, 14, 1790-1800.
92. Sahlgren, C.; Gustafsson, M. V.; Jin, S.; Poellinger, L.; Lendahl, U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc. Natl. Acad. Sci. USA 2008, 105, 6392-6397.
93. Radisky, D. C.; Levy, D. D.; Littlepage, L. E.; Liu, H.; Nelson, C. M.; Fata, J. E.; Leake, D.; Godden, E. L. Albertson, D. G.; Nieto, M. A.; Werb, Z.; Bissell, M. J. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005, 436, 123-127.
94. Park, J.; Schwarzbauer, J. E. Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition. Oncogene 2013. [Epub ahead of print]
95. Yamada, N.; Kitamoto, S.; Yokoyama, S.; Hamada, T.; Goto, M.; Tsutsumida, H.; Higashi, M.; Yonezawa, S. Epigenetic regulation of mucin genes in human cancers. Clin. Epigenetics 2011, 2, 85-96.